Mariane H. Schleimann

Arhus, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Selective infection and loss of PRDM1+ LN Tfh cells in uncontrolled HIV infection precludes formation of Tfh reservoirs under ART.

Selective infection and loss of PRDM1+ LN Tfh cells in uncontrolled HIV infection precludes formation of Tfh reservoirs under ART.

Journal: bioRxiv : the preprint server for biology
Published: December 25, 2025

Immunological dysfunction associated with SARS-CoV-2 persistence in immunocompromised patients.

Immunological dysfunction associated with SARS-CoV-2 persistence in immunocompromised patients.

Journal: Clinical and experimental immunology
Published: September 11, 2025

TCR bias drives development of dominant vaccine-induced CD8+ T cell responses which can be redirected toward cellular targets.

TCR bias drives development of dominant vaccine-induced CD8+ T cell responses which can be redirected toward cellular targets.

Journal: Vaccine
Published: June 30, 2025

Long-term HIV-1 remission achieved through allogeneic haematopoietic stem cell transplant from a CCR5Δ32/Δ32 sibling donor.

Long-term HIV-1 remission achieved through allogeneic haematopoietic stem cell transplant from a CCR5Δ32/Δ32 sibling donor.

Journal: Nature microbiology
Published: June 23, 2025

Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control.

Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control.

Journal: Nature immunology
Published: June 04, 2025

Vectored long-term co-delivery of antibodies for SARS-CoV-2, RSV and Influenza prophylaxis.

Vectored long-term co-delivery of antibodies for SARS-CoV-2, RSV and Influenza prophylaxis.

Journal: Virology
Published: February 21, 2025

TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity.

TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity.

Journal: Scientific reports
Published: November 06, 2023

Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial.

Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial.

Journal: Nature medicine
Published: May 16, 2023

Discovery of neutralizing SARS-CoV-2 antibodies enriched in a unique antigen specific B cell cluster.

Discovery of neutralizing SARS-CoV-2 antibodies enriched in a unique antigen specific B cell cluster.

Journal: PloS one
Published: May 03, 2023

Single cell analysis reveals a subset of cytotoxic-like plasmacytoid dendritic cells in people with HIV-1.

Single cell analysis reveals a subset of cytotoxic-like plasmacytoid dendritic cells in people with HIV-1.

Journal: iScience
Published: April 06, 2023

A novel SARS-CoV-2 Beta RBD DNA vaccine directly targeted to antigen-presenting cells induces strong humoral and T cell responses.

A novel SARS-CoV-2 Beta RBD DNA vaccine directly targeted to antigen-presenting cells induces strong humoral and T cell responses.

Journal: Scientific reports
Published: January 02, 2023

Development of HIV-Resistant CAR T Cells by CRISPR/Cas-Mediated CAR Integration into the CCR5 Locus.

Development of HIV-Resistant CAR T Cells by CRISPR/Cas-Mediated CAR Integration into the CCR5 Locus.

Journal: Viruses
Published: December 21, 2022
Showing 1-12 of 33

Last Updated: 09/26/2026